| |
Featured Products
LGM Pharma is proud to present to you our new line of "Gliptin" Active Pharmaceutical Ingredients:
This small group of hypoglycemic API's (anti-diabetic drugs), nicknamed "gliptins", are available for prompt delievery. Their longer name is Dipeptidyl peptidase-4 inhibitors or DPP-4 inhibitors.
Read our Gliptins blog article discussing the report published last month in Medpage Today >
LGM Pharma is committed to providing full sourcing options and support for the widest range of rare and new APIs in the R&D community.
|
Relatively new drugs (such as the proton pump inhibitor Lansoprazole CAS# 103577-45-3) have a greater treatment role in certain disorders and diseases than what they were initially approved for. In light of these developments, LGM Pharma has not only kept its focus on the market for new studies, but it has also been a consistent supplier of Lansoprazole CAS# 103577-45-3. By lending their hand as a responsive supplier, the company believes that it has helped to invigorate similar research efforts by pharmaceutical organizations worldwide...
Read more on our blog >
|
|
|
|
|
Recent Blog Posts
|
|
